There are 2789 resources available
1344P - Molecular features of young cannabis smokers with advanced non-small cell lung cancer (aNSCLC)
Presenter: Mihaela Aldea
Session: ePoster Display
1265P - Combined detection of tumor markers and ctDNA in cerebrospinal fluid: A good strategy in diagnosis of leptomeningeal metastases
Presenter: Yong Wang
Session: ePoster Display
1307P - Real-world evaluation of first-line (1L) pembrolizumab (pembro) monotherapy for PD-L1–positive (TPS ≥50%), advanced NSCLC in Japan
Presenter: Yasushi Goto
Session: ePoster Display
1308P - Efficacy and safety of anti-PD-1 therapy plus anlotinib in previously treated advanced NSCLC
Presenter: Xin Lv
Session: ePoster Display
1309P - A multicenter phase I study of radium-223 (Ra-223) plus pembrolizumab in patients with stage IV non-small cell lung cancer (NSCLC)
Presenter: Martin Reck
Session: ePoster Display
1310P - Toripalimab combined with chemotherapy as second-line treatment of advanced non-small cell lung cancer (NSCLC): A single center retrospective study
Presenter: man Jiang
Session: ePoster Display
1311P - The role of inflammatory biomarkers in advanced non-small cell lung cancer patients treated with chemo-immunotherapy
Presenter: Emma Zattarin
Session: ePoster Display
1312P - Prognostic impact of KRAS status in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitor monotherapy
Presenter: Giacomo Pelizzari
Session: ePoster Display
1383P - Phase I study of the irreversible FGFR inhibitor futibatinib in Japanese patients with advanced solid tumors: Updated dose expansion results and activity in gastric cancer
Presenter: Yasutoshi Kuboki
Session: ePoster Display